Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Otolaryngologic Clinics of North AmericaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Overview of systematic reviews in allergy epidemiology.Allergy. 2017; 7: 12https://doi.org/10.1186/s13601-017-0146-y
- State-of-the-art overview on biological treatment for CRSwNP.Rhinology. 2021; 59: 151-163
- Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.Allergy. 2020; 75: 1023-1042
- Biological treatment in allergic disease.Allergy. 2021; 76: 2934-2937
- Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP.Rhinology. 2021; 59: 301-311
- Quality of life in allergic rhinitis and asthma. A population-based study of young adults.Am J Respir Crit Care Med. 2000; 162: 1391-1396
- European position paper on rhinosinusitis and nasal polyps 2020.Rhinology. 2020; 58: 1-464
- Burden of allergic respiratory disease: a systematic review.Clin Mol Allergy. 2016; 14: 12
- The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life.Rhinology. 2019; 57: 343-351
- Investigating the secondary care system burden of CRSwNP in sinus surgery patients with clinically relevant comorbidities using the HES database.Rhinology. 2022; 60: 252-260
- Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.J Allergy Clin Immunol. 2013; 131: 1479-1490
- Adult-onset eosinophilic airway diseases.Allergy. 2020; 75: 3087-3099
- Regulation of interaction between the upper and lower airways in united airway disease.Med Sci (Basel). 2019; 7: 27https://doi.org/10.3390/medsci7020027
- Self-reported nasal hyperreactivity is common in all chronic upper airway inflammatory phenotypes and not related to general well-being.Allergy. 2021; 76: 3806-3809
- Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma.World Allergy Organ J. 2020; 13: 100132
- Prevalence and impact of nasal hyperreactivity in chronic rhinosinusitis.Allergy. 2020; 75: 1768-1771
- Towards a new epidemiological definition of chronic rhinitis: prevalence of nasal complaints in the general population.Rhinology. 2021; 59: 258-266
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers.J Allergy Clin Immunol. 2016; 137 (e4): 1449-1456
- Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis.J Allergy Clin Immunol Pract. 2019; 7: 2812-2820.e3
- The Complex type 2 endotype in allergy and asthma: from laboratory to bedside.Curr Allergy Asthma Rep. 2015; 15: 29
- Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report.Allergy. 2015; 70: 474-494
- Asthma in combination with rhinitis and eczema is associated with a higher degree of type-2 inflammation and symptom burden than asthma alone.Allergy. 2021; 76: 3827-3829
- Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation.Allergy. 2020; 75: 2794-2804
- Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.Allergy. 2022; 77: 812-826
- Differences and similarities between the upper and lower airway: focusing on innate immunity.Rhinology. 2021; 59: 441-450
- Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease.Rhinology. 2016; 54: 195-205
- Innate and adaptive immunity: ILC2 and Th2 Cells in upper and lower airway allergic diseases.J Allergy Clin Immunol Pract. 2021; 9: 1851-1857
- Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.Sci Immunol. 2021; 6: eabd3489
- Nasal epithelium: new insights and differences of the cytokine profile between normal subjects and subjects with allergic rhinitis.Rhinology Online. 2021; 4: 223-232
- Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier.PLoS One. 2013; 8: e53337
- Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.J Allergy Clin Immunol. 2016; 137: 1043-1053.e1-5
- Epithelial barriers in allergy and asthma.J Allergy Clin Immunol. 2020; 145: 1499-1509
- Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.Allergy. 2021; 76: 3459-3469
- Barrier disruptive effects of mucus isolated from chronic rhinosinusitis patients.Allergy. 2020; 75: 200-203
- Synergy between TLR-2 and TLR-3 signaling in primary human nasal epithelial cells.Immunobiology. 2015; 220: 445-451
- Toll-like receptor 4 plays significant roles during allergic rhinitis.Allergologia et Immunopathologia. 2015; 43: 416-420
- Expression profiling and functional analysis of Toll-like receptors in primary healthy human nasal epithelial cells shows no correlation and a refractory LPS response.Clin Translational Allergy. 2015; 5: 42
- Primary nasal epithelium exposed to house dust mite extract shows activated expression in allergic individuals.Am J Respir Cell Mol Biol. 2008; 38: 293-299
- EGR-1 and DUSP-1 are important negative regulators of pro-allergic responses in airway epithelium.Mol Immunol. 2015; 65: 43-50
- Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.Nat Immunol. 2011; 12: 1055-1062
- Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.Allergy. 2018; 73: 837-850
- Insights into group 2 innate lymphoid cells in human airway disease.Curr Allergy Asthma Rep. 2016; 16: 8
- Nasal involvement in allergic asthma.Allergy. 2003; 58: 1235-1243
- Mouth breathing, another risk factor for asthma: the Nagahama Study.Allergy. 2016; 71: 1031-1036
- United airways concept: what does it teach us about systemic inflammation in airways disease?.Proc Am Thorac Soc. 2009; 6: 652-654
- Simulated postnasal mucus fails to reproduce the symptoms of postnasal drip in rhinitics but only in healthy subjects.Rhinology. 2015; 53: 129-134
- Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.Am J Respir Crit Care Med. 2000; 161: 2051-2057
- Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa.Am J Respir Crit Care Med. 2001; 164: 858-865
- Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways.J Allergy Clin Immunol. 2001; 107: 469-476
- CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation.J Allergy Clin Immunol. 2009; 123: 472-478
- Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.Clin Exp Allergy. 2005; 35: 34-38
- Risk factors for frequent severe exacerbations in late-onset eosinophilic asthma.Am J Respir Crit Care Med. 2015; 192: 899-902
- Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.Eur Respir J. 2020; 55: 1901592
- Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma.Allergy. 2020; 75: 3039-3068
- Advances and highlights in biomarkers of allergic diseases.Allergy. 2021; 76: 3659-3686
- Nasal nitric oxide in chronic rhinosinusitis with or without nasal polyps: a systematic review with meta-analysis.J Clin Med. 2020; 9: 200
- European position paper on diagnostic tools in rhinology.Rhinology. 2019; 57: 1-41
- Global initiative for asthma strategy 2021: executive summary and rationale for key changes.Eur Respir J. 2022; 59: 2102730
- Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.Allergy. 2013; 68: 569-579
- Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.Allergy. 2022; 77: 1719-1735
- A systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis.Int Forum Allergy Rhinology. 2013; 3: 788-794
- The effects of endoscopic sinus surgery on pulmonary function in chronic rhinosinusitis patients with asthma: a systematic review and meta-analysis.Eur Arch Otorhinolaryngol. 2019; 276: 1405-1411
- Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis.Rhinology. 2015; 53: 10-17
- Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma.J Allergy Clin Immunol. 2015; 135: 701-709.e5
- Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines.Allergy. 2021; 76: 2337-2353
- Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST.Allergy. 2021; 76: 2621-2624
- Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.Allergy. 2022; 77: 1231-1244
- Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps.Allergy. 2022; 77: 670-674
- Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.Clin Translational Allergy. 2020; 10: 1
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
